Search clinical trials for: JAK Inhibitor
Total 65034 results
-
Eli Lilly and CompanyIncyte CorporationCompletedArthritis, RheumatoidHungary, Romania, United States, Czechia, Croatia, Poland, Ukraine, Mexico, India
-
Eli Lilly and CompanyCompleted
-
Leiden University Medical CenterGalapagos NVRecruiting
-
Shanghai East HospitalActive, not recruitingAcneiform EruptionsChina
-
CTI BioPharmaTerminatedCOVID-19 | COVID | COVID19United States
-
Incyte CorporationTerminatedCOVID-19United States, Russian Federation
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingDermatomyositis, Adult TypeChina
-
Tang-Du HospitalNot yet recruitingSpontaneous Subarachnoid Hemorrhage
-
William ShomaliIncyte CorporationRecruitingEosinophilia | Hypereosinophilic Syndrome | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Splenomegaly | Hepatomegaly | Chronic Eosinophilic Leukemia, Not Otherwise Specified | JAK2 Gene Mutation | BCR-JAK2 Fusion Protein Expression | Blasts 20 Percent or Less of Peripheral Blood White... and other conditionsUnited States
-
Liga Panamericana de Asociaciones de Reumatologia...RecruitingArthritis, Rheumatoid | Arthritis, Psoriatic | SpondyloarthritisArgentina
-
John ReneauRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
National Cancer Institute (NCI)Not yet recruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory High Risk Myelodysplastic Syndrome
-
Matthew J KosterEli Lilly and CompanyCompleted
-
Bristol-Myers SquibbTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Steroid Refractory Graft Versus Host DiseaseUnited States
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingSolid Tumors | ER+ Breast Cancer | ARID1A Gene Mutation | Triple Negative Breast Cancer, TNBC | Small Cell Lung Cancer, SCLCUnited States, China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Untreated Chronic Lymphocytic LeukemiaUnited States
-
University of WashingtonRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Secondary Myelofibrosis | Myeloproliferative Neoplasm, UnclassifiableUnited States
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
MBQ PharmaCongressionally Directed Medical Research ProgramsRecruitingBreast Cancer | Breast Neoplasm | Breast Cancer Stage IVPuerto Rico
-
Brian DrukerAbbVie; Oregon Health and Science University; Incyte CorporationActive, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelofibrosisUnited States
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell CarcinomaChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...RecruitingIntracranial Meningioma | Recurrent Meningioma | NF2 Gene MutationUnited States
-
Pi Research Consultancy Center, BangladeshNot yet recruitingVitiligo | Effect of Drug
-
Jacobio Pharmaceuticals Co., Ltd.RecruitingColorectal Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Carcinoma | KRAS P.G12CChina
-
Neurocrine BiosciencesTakedaTerminatedSchizophrenia, Cerebellar AtaxiaUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedA Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic HypersomniaIdiopathic HypersomniaUnited States, Japan
-
TakedaWithdrawnHealthy VolunteersUnited States
-
Neurocrine BiosciencesTakedaCompletedFriedreich AtaxiaUnited States
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompletedJapanese Healthy Adult MaleJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompleted
-
TakedaTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
TakedaTerminatedCardiovascular Disease | Type 2 DiabetesUnited States, France, Poland, Ukraine, Germany, Hong Kong, Taiwan, Argentina, Israel, Mexico, Bulgaria, Malaysia, Romania, Canada, Korea, Republic of, New Zealand, Peru, Estonia, Philippines, Russian Federation, Czech Republic, H... and more
-
TakedaWithdrawn
-
Millennium Pharmaceuticals, Inc.Completed
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaRichmond Pharmacology LimitedCompleted
-
TakedaCompletedHealthyUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
Kasr El Aini HospitalRecruiting
-
TakedaCompletedMyasthenia GravisUnited States, Spain, Canada, Serbia, Italy, Poland
-
Kissei Pharmaceutical Co., Ltd.CompletedExtravasations of Anthracycline Anti-cancer AgentsJapan
-
TakedaTakeda Development Center Americas, Inc.TerminatedCrohn DiseaseUnited States, Germany, Austria, France, United Kingdom